In terms of the three most common subtypes, ORR was seen in 23 % of patients with PTCL-NOS, 46 % in AITL, and 15 % in ALK-negative ALCL. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.